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Abstract
Background: Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion.
We set out to determine the prevalence of MetS and its components in different ethnic groups.
Methods: This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces
in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult
Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for
deriving odds ratios and 95% confidence intervals of risk factors for the MetS.
Results: The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the
prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90%
(Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in
five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL
cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a
higher risk of MetS.
Conclusions: Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean
ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the
ethnic groups within a population.
Keywords: Metabolic syndrome, Ethnic group, China
Background
Metabolic Syndrome (MetS) is a cluster of related abnor-
malities that include abdominal obesity, insulin resistance,
dyslipidaemia and elevated blood pressure [1, 2]. The Na-
tional Cholesterol Education Program’s Adult Treatment
Panel III (NCEP: ATPIII), World Health Organization
(WHO) and International Diabetes Federation (IDF) use
this syndrome to highlight the risk of patients developing
cardiovascular disease (CVD) and type 2 diabetes (T2DM)
[1, 3]. We previously reported that the prevalence of MetS
in the United States was 33·6% in the adult population [4].
MetS predicts the development of diabetes [5] and hyper-
tension [6], and is also associated with coronary artery dis-
ease (CAD) [7] and increased mortality [8].
While the natural history of MetS and how it develops
have been well described in Hong Kong Chinese, a large
number of observational studies have also been conducted
in China, the population of which is mostly of Han ethni-
city [9, 10]. A meta-analysis showed that the pooled preva-
lence of MetS in China was 24·5% among subjects aged
over 15 years. Individuals living in urban areas had a
higher risk of having MetS than those living in rural areas
[11]. However, China is a multi-ethnic country with at
least 55 ethnic groups. There are few studies focused on
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MetS among different ethnic groups in China, and most
of these studies focused on a single ethnic group [7, 12,
13]. The heterogeneity in study design, inclusion criteria
and definition of MetS makes it difficult to compare the
prevalence in different ethnic groups.
Building on the Expansion Investigation of Human
Physiology Constant Study in China [14], we made use of
unified inclusion criteria and centralized measurements to
determine the prevalence of Metabolic Syndrome (MetS)
among different ethnicities in six provinces of China using
the modified NCEP: ATPIII criteria [15].
Methods
Description of the study
The Expansion Investigation of Human Physiology Con-
stant was a nationwide cross-sectional, random and multi-
stage clustering sampled survey in China that is part of the
National Constitution and Health Database in 2008–2011
[16]. Our previous studies based on the National Constitu-
tion and Health Database had shown several factors associ-
ated with cardiovascular disease [14, 17]. This study was
expanded to six provinces and eight ethnic groups
according to the geographical, ethnical and economic char-
acteristics from the previous studies. All study personnel
was trained with standardised working manuals and surveys
before they conducted this study. Sample processing, testing
and quality control were conducted by certified personnel
in a central laboratory (Department of Laboratory Medicine
in Peking Union Medical College Hospital) to ensure the
consistency and stability of the measurements.
Subjects
Participants aged 8–86 years were recruited from six prov-
inces (Inner Mongolian, Heilongjiang, Ningxia, Hunan,
Yunnan, Sichuan) using a random, multistage cluster-
sampling method as shown in Fig. 1. Eight ethnic groups,
including Han, Mongolian, Korean, Hui, Miao, Li, Tibetan
and Tujia, were enrolled in this study. Inclusion criteria
were absence of self-reported systemic diseases, such as
CAD, renal disease, autoimmune disease, hypersensitivity,
gastrointestinal disease, pulmonary disease, and cancer.
Considering different customs of ethnic groups, we in-
cluded participants aged 8–86. Exclusion criteria included
significant abnormalities on physical examination, and
Fig. 1 Distributions of participants in China
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having a fever, acute illness, or hospitalization within 15
days. This study was approved by the Ethics Committee of
Institute of Basic Medical Sciences Chinese Academy of
Medical Sciences (No·005–2008). Written consents were
obtained from all participants.
Data collection
Participants were required to complete a demographic
questionnaire and a health behaviour questionnaire,
which included smoking, alcohol consumption and phys-
ical activity. Trained personnel assisted the participants
in completing the questionnaires.
Measurements
All participants were asked to avoid smoking and heavy
physical activity for at least 2 h before the physical exami-
nations, which included resting blood pressure, height,
weight, and waist circumference (WC). Two blood pres-
sure measurements were taken using OMRON HEM-
7000 electronic sphygmomanometer (OMRON Health-
Care, Kyoto, Japan) after the participants had rested in a
sitting position for at least 5 min.
Participants were required to fast for 8 to 12 h before
blood sampling. Fasting blood glucose (GLU), total chol-
esterol, triglycerides, high-density lipoprotein cholesterol
(HDL cholesterol), and low-density lipoprotein choles-
terol (LDL cholesterol) were analysed using a Hitachi
7020 chemistry analyser (Hitachi, Tokyo, Japan). Body
mass index (BMI) was a person’s weight in kilograms
divided by the square of height in meters.
Definition of metabolic syndrome
The modified ATP III criteria were applied in the diag-
nosis of MetS, which requires the presence of at least
three out of five factors [15]: (i) Abdominal density as
defined by waist circumference ≥ 90 cm in men and ≥ 80
cm in women; (ii) triglycerides ≥1·7 mmol/L; (iii) HDL
cholesterol < 1·03 mmol/L in men and < 1·29 mmol/L in
women; (iv) systolic blood pressure (SBP) ≥130 mmHg
or diastolic blood pressure (DBP) ≥ 85mmHg; (v) GLU
≥5·6 mmol/L as impaired fasting glucose (IFG).
Statistical analysis
Results were analysed using SPSS version 22·0 (IBM SPSS
Statistics, Armonk, NY, USA) in 2018. Descriptive statistics
were expressed as frequency (percentage) for categorical
data or mean ± SD or median (interquartile range) for con-
tinuous variables. Missing data were less than 3% for all in-
cluded variables. Continuous variables were compared
among groups using one-way ANOVA and Kruskal-Wallis
tests as appropriate. Categorical variables were compared
among groups using Chi-square test. Logistic regression
was used to identify the predictors for MetS. Gender, age,
ethnicities, exercises, smoking status, drinking status were
included in the model. Age groups and gender were
entered into the first adjusted model. Other predictor vari-
ables were entered stepwise if P < 0·05 and removed if P >
0·10. Exercise was added as a covariate in the second ad-
justed model and ethnicities, drinking status, smoking sta-
tus were applied in the third adjusted model. Odds ratios
(ORs) and 95% confidential interval (95% CI) were esti-
mated. A two-tailed P < 0·05 was considered statistically
significant. Data from the Sixth National Population Cen-
sus of the People’s Republic of China provided by the Na-
tional Statistics Bureau of China were used as the standard
population. Age-specific prevalence and age-standardized
prevalence were estimated from the standard population.
Results
A total of 24,796 participants were enrolled in this study
(Fig. 2). The characteristics are summarized in Supple-
mentary Table 1. There was a significant difference in
the median age among participants from different prov-
inces and ethnic groups (shown in Supplementary
Table 1, 2 and 3). Compared with Hans in the same
province, participants from Tibetan, Miao, Tujia, Mon-
golian, Li ethnic groups were younger (P < 0·001).
The prevalence of MetS in eight ethnic groups of China
The age, gender and ethnic-specific crude and standar-
dised prevalence of MetS are summarised in Table 1.
The prevalence of MetS in males (13·5%) was slightly
higher than in females (12·6%) (P = 0·28). The prevalence
of MetS was substantially higher above age 25 (24·7%)
compared with age ≤ 25 (2·3%) (P < 0·001). There was a
significant difference in MetS prevalence among ethnic
groups (P < 0·001). Korean Chinese had the highest
prevalence of 35·42, followed by Hui, Han, Miao, Tujia,
Li, Mongolian and Tibetan (Table 1, Fig. 3).
The prevalence of MetS components
Figure 4 shows the prevalence of components of MetS
in different ethnic groups. The highest prevalence of ab-
dominal obesity, hyperlipidaemia, decreased HDL chol-
esterol, elevated blood pressure and IFG were found in
Han, Li, Hui, Li and Korean ethnicities, respectively;
Fig. 2 A flow diagram for inclusion of study samples
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while the lowest prevalence of the components of MetS
appeared in Li and Tibetan ethnicities (Fig. 4). In all ethnic
groups, the prevalence of decreased HDL cholesterol and
elevated blood pressure were the two highest among the
five components, while IFG was less prevalent, especially
in Miao, Mongolian, Tibetan, Hui and Tujia ethnicities.
Predictors for MetS
Predictors for MetS are summarized in Table 2. Age, gen-
der, smoking, alcohol consumption and ethnic groups were
all significant risk factors for MetS in the crude model (p <
0·001, p = 0·027, p < 0·001, p < 0·001, p < 0·001, respectively).
Compared to females, males had an increased risk of MetS
[OR (95% CI): 1·087 (1·009–1·171), p = 0·027]. However,
maleness [1·028 (0·930–1·137), p = 0·059] and smoking
[0·908 (0·806–1·022), p = 0·110] were not significant factors
for MetS after multivariable adjustment. Compared to par-
ticipants aged 8 to 12 years, the OR increased with age, and
was highest in participants aged 60 to 86 years [34·117
(24·673–47·177), p < 0·001]. Relative to Tibetans, all other
ethnicities were associated with increased risk of MetS.
Korean Chinese had the highest adjusted risk for MetS
[5·989 (4·249–8·442), p < 0.001], followed by Hui [4·020
(2·859–5·653), p < 0.001], Han [2·975 (2·194–4·034), p <
0.001], Li [2·096 (1·487–2·954), p < 0·001], Miao [1·961
(1·262–3·048), p = 0·003], Mongolian [1·835 (1·272–2·648),
p = 0·001] and Tujia [1·753 (1·166–2·637), p = 0·007] ethnic-
ities. MetS was not significantly associated with exercise in
both crude and adjusted models (P = 0·140, P = 0·710,
P = 0·710, P = 0·905, respectively).
Discussion
This study is the first large-scale multi-ethnic investiga-
tion of the prevalence of MetS in China. With 24,796
participants, it had sufficient power to estimate and
compare prevalence in subgroups. Such comparisons are
also valid and reliable because we had standardised pro-
tocols, rigorous quality control and a central clinical la-
boratory for measurements. The large sample size,
standardised measurements and the quality control
allowed us to have accurate estimates of the prevalence
of MetS in the general population in China. It is a
Fig. 3 Standardized Prevalence of MetS in ethnic groups in China stratified by gender
Fig. 4 The prevalence of MetS components in ethnic groups in China
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strength of the study to recruit from the age of 8 to 86,
which is an uncommonly wide range for an epidemio-
logical study. The study did not recruit subjects below
the age of 8 or above the age of 86 for practical reasons.
The prevalence of MetS in Hans in the present study
was higher than a previous national study in China [18],
but lower or similar to the prevalence in US and Europe
[19, 20]. Due to economic development, consumption of
dairy products and fast foods had doubled [21, 22], which
might have contributed to the increasing trend in MetS.
The prevalence of MetS was slightly higher in men in this
study, in contrast to some other populations [23].
The prevalence of MetS in Korean, Hui and Mongolian
Chinese in our study is relatively higher than previous
studies’ in these ethnicities [24–26]. A study using the Ko-
rean National Health and Nutrition Examination Survey
(KNHANES) data from 2008 to 2013 reported that the
prevalence of MetS among the Korean participants aged
≥20 years was 28·9% according to the modified NCEP:
ATPIII definition [25]. A study conducted among rural
adults in Ningxia in 2008 reported that the age-adjusted
prevalence of MetS was 13·7% with International Diabetes
Federation definition [26]. In Mongolians aged over 18
years, the prevalence of MetS in men was higher than in
women (36·7% vs. 17·8%) [24]. However, a study of Ti-
betan immigrants in India aged over 20 years reported a
prevalence of 10·6% in men and 33·3% in women [27]. In
our study, Tibetans had a much lower prevalence of MetS
as a result of possible volunteer bias.
This study revealed that the prevalence of the compo-
nents of MetS varied greatly in different ethnicities. These
differences may be due to genetic factors and environmen-
tal factors, which include diet and lifestyle. A randomized
dietary and behavioural interventional study showed that
a Tibetan diet reduced body weight and BMI in patients
with CAD and MetS [28]. This might be the reason why
Tibetans in our study had a low prevalence of MetS. The
increased prevalence of MetS in Korean ethnicity might
also be explained by diet, since it has been shown that
dietary intakes of total fat and saturated fatty acids were
significantly associated with MetS [29].
The association of gender with MetS is controversial
[30–32]. In this study, the association of maleness with
MetS was weak and became not significant in the multi-
variable model. In previous studies, it have been shown
that advanced age and drinking status were both associ-
ated with higher risk of MetS, while the association with
exercise and smoking status was equivocal [33–35]. Our
finding that Chinese of Korean and Tibetan ethnicities
had the highest and lowest prevalence for MetS respect-
ively should prompt further studies to explore the pos-
sible causes of ethnic difference in the risk of developing
Table 2 Predictors of metabolic syndrome
Parameters Crude model Adjusted model 1 Adjusted model 2 Adjusted model 3
Male 1·087 (1·009–1·171) 1·110 (1·024–1·202) 1·110 (1·025–1·203) 1·028 (0·930–1·137)
Exercise 0·941 (0·867–1·020) 1·017 (0·931–1·110) 1·017 (0·931–1·110) 1·006 (0·911–1·111)
Smoking Status 1·867 (1·702–2·048) ^ 0·977 (0·873–1·093) 0·979 (0·875–1·096) 0·908 (0·806–1·022)
Drinking Status 2·159 (1·975–2·360) ^ 1·322 (1·186–1·472) ^ 1·320 (1·184–1·470) ^ 1·348 (1·203–1·509) ^
Age groups 8–12 1 (reference) 1 (reference) 1 (reference) 1(reference)
13–17 1·767 (1·282–2·435) 1·770 (1·285–2·440) ^ 1·769 (1·283–2·438) ^ 1·712 (1·208–2·425)
18–24 1·870 (1·306–2·677) 1·867 (1·304–2·674) 1·863 (1·301–2·669) 1·727 (1·176–2·535)
25–39 12·191 (9·090–16·350) ^ 12·242 (9·128–16·418) ^ 12·238 (9·125–16·414) ^ 11·67 (8·452–16·113) ^
40–59 26·041 (19·516–34·747) ^ 26·16 (19·605–34·907) ^ 26·162 (19·606–34·910) ^ 24·583 (17·892–33·776) ^
60–86 38·350 (28·512–51·584) ^ 38·225 (28·418–51·416) ^ 38·176 (28·38–51·354) ^ 34·117 (24·673–47·177) ^
Ethnic groups Tibetan 1 (reference) 1 (reference) 1 (reference) 1(reference)
Han 4·482 (3·358–5·982) ^ 2·917 (2·165–3·930) ^ 2·916 (2·165–3·929) ^ 2·975 (2·194–4·034) ^
Li 3·243 (2·356–4·465) ^ 1·991 (1·431–2·771) ^ 1·984 (1·417–2·778) ^ 2·096 (1·487–2·954) ^
Miao 3·043 (2·004–4·620) ^ 1·877 (1·213–2·903) 1·877 (1·214–2·904) 1·961 (1·262–3·048)
Mongolian 1·955 (1·382–2·765) ^ 1·815 (1·266–2·602) 1·815 (1·266–2·602) 1·835 (1·272–2·648)
Korean 7·436 (5·419–10·205) ^ 6·116 (4·377–8·547) ^ 6·112 (4·373–8·543) ^ 5·989 (4·249–8·442) ^
Hui 3·893 (2·835–5·345) ^ 3·629 (2·605–5·054) ^ 3·625 (2·602–5·052) ^ 4·020 (2·859–5·653) ^
Tujia 3·271 (2·219–4·824) ^ 1·721 (1·151–2·575) 1·722 (1·151–2·576) 1·753 (1·166–2·637)
Data is expressed as odds ratio (95% confidence interval)
^p < 0·001
Adjusted model 1: adjusted for gender, age groups
Adjusted model 2: adjusted for gender, age groups and exercises
Adjusted model 3: adjusted for gender, age groups, exercises, ethnicities, smoking status and drinking status
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MetS. Such studies should include a detailed dietary and
lifestyle survey, and a study of socioeconomic and gen-
etic factors.
Limitations
There were some limitations in this study. China is a large
country, so 24,796 participants represent only a small frac-
tion of the total population. We were unable to study mi-
norities in very remote parts of China. Different ethnic
groups have different religious beliefs and customs, and
these may account for some of the differences.
Conclusions
In this large multi-ethnic population-based survey, the
age-standardized prevalence of MetS varied greatly in
different ethnic groups, ranging from 6·18% to 35·43%.
Korean ethnicity was associated with a higher prevalence
of MetS and its components, while Tibetan ethnicity was
associated with a lower prevalence of MetS and its com-
ponents except decreased HDL cholesterol.
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